Salmonella typhi uses CFTR for intestinal translocation, providing a basis for the heterozygote advantage in cystic fibrosis

G Pier, M Grout, T Zaidi, G Meluleni, SS Mueschenborn, GS Banting, R Ratcliffe, MJ Evans, WH Colledge

Research output: Contribution to journalArticle (Academic Journal)peer-review

283 Citations (Scopus)
Translated title of the contributionSalmonella typhi uses CFTR for intestinal translocation, providing a basis for the heterozygote advantage in cystic fibrosis
Original languageEnglish
Pages (from-to)79 - 82
JournalNature
Volume393
Publication statusPublished - 1998

Cite this